{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:53:24Z","timestamp":1793386404974,"version":"4.5.0"},"reference-count":27,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.25122\/jml-2025-0071","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:05:33Z","timestamp":1763388333000},"page":"821-829","source":"Crossref","is-referenced-by-count":2,"title":["Comparative impact of direct oral anticoagulants and vitamin K antagonists on cognitive function in atrial fibrillation patients: a systematic review and meta-analysis"],"prefix":"10.25122","volume":"18","author":[{"given":"Amr Ahmed","family":"Fouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Eisa","family":"Alkathiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind Abdulrahim","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamis Atef","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Tabuk University, Tabuk, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowaid Khalid","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad Ahmad","family":"Alhikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf Mohammed","family":"Alanasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Tabuk University, Tabuk, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem Matoqq","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Jeddah University, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad Eesa","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Jeddah University, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Naif","family":"Alfaheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen Fahd","family":"Alabbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Bakri","family":"Alnashri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah Mohammed","family":"Alaqwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Medicine, Vision Colleges, Riyadh, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaf Mahmud","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Medicine, Ibn Sina National College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama Jamel","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"College of Applied Medical Science, Taif University, Taif, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"200282","DOI":"10.1016\/j.ijcrp.2024.200282","article-title":"The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis","volume":"21","author":"Latif F, Nasir MM, Meer KK, Farhan SH, Cheema HA, Khan AB","year":"2024","unstructured":"1. Latif F, Nasir MM, Meer KK, Farhan SH, Cheema HA, Khan AB, The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis, Int J Cardiol Cardiovasc Risk Prev, 2024;21200282","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"8","key":"ref2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/clc.24076","article-title":"A comparison of the effects of NOAC and VKA therapy on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis","volume":"46","author":"Wang W, Fan W, Su Y, Hong K","year":"2023","unstructured":"2. Wang W, Fan W, Su Y, Hong K, A comparison of the effects of NOAC and VKA therapy on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis, Clin Cardiol, 2023;46(8):866-876","journal-title":"Clin Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1265331","DOI":"10.3389\/fcvm.2023.1265331","article-title":"Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis","volume":"10","author":"Wang D, Xu X, Han X, Xie J, Zhou H, Peng W","year":"2023","unstructured":"3. Wang D, Xu X, Han X, Xie J, Zhou H, Peng W, Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis, Front Cardiovasc Med, 2023;101265331","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"ref4","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1161\/STROKEAHA.120.033338","article-title":"Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation","volume":"52","author":"Lee SR, Choi EK, Park SH, Jung JH, Han KD, Oh S","year":"2021","unstructured":"4. Lee SR, Choi EK, Park SH, Jung JH, Han KD, Oh S, Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation, Stroke, 2021;52(11):3459-3468","journal-title":"Stroke"},{"issue":"8","key":"ref5","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3390\/jcm13082418","article-title":"Exploring the Link between Anticoagulation, Cognitive Impairment and Dementia in Atrial Fibrillation: A Systematic Review","volume":"13","author":"Agarwal A, Mostafa MA, Ahmad MI, Soliman EZ","year":"2024","unstructured":"5. Agarwal A, Mostafa MA, Ahmad MI, Soliman EZ, Exploring the Link between Anticoagulation, Cognitive Impairment and Dementia in Atrial Fibrillation: A Systematic Review, J Clin Med, 2024;13(8):2418","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fcvm.2019.00155","article-title":"Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF","volume":"6","author":"McManus DD, Kiefe C, Lessard D, Waring ME, Parish D, Awad HH","year":"2019","unstructured":"6. McManus DD, Kiefe C, Lessard D, Waring ME, Parish D, Awad HH, Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF, Front Cardiovasc Med, 2019;6155","journal-title":"Front Cardiovasc Med"},{"issue":"34","key":"ref7","doi-asserted-by":"publisher","first-page":"e12072","DOI":"10.1097\/MD.0000000000012072","article-title":"Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies","volume":"97","author":"Shen L, Zhang C, Gu ZC, Lin HW, Liu XY, Pu J","year":"2018","unstructured":"7. Shen L, Zhang C, Gu ZC, Lin HW, Liu XY, Pu J, Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies, Medicine (Baltimore), 2018;97(34):e12072","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"ref8","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group","year":"2009","unstructured":"8. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 2009;6(7):e1000097","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A","year":"2016","unstructured":"9. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A, Rayyan\u2014a web and mobile app for systematic reviews, Syst Rev, 2016;5210","journal-title":"Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I","year":"2019","unstructured":"10. Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 2019;366l4898","journal-title":"BMJ"},{"issue":"9","key":"ref11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J","year":"2003","unstructured":"11. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J, Methodological index for non-randomized studies (minors): development and validation of a new instrument, ANZ J Surg, 2003;73(9):712-6","journal-title":"ANZ J Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejim.2023.10.033","article-title":"Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation","volume":"121","author":"Sagris D, Ntaios G, Buckley BJR, Harrison SL, Underhill P, Lane DA","year":"2024","unstructured":"12. Sagris D, Ntaios G, Buckley BJR, Harrison SL, Underhill P, Lane DA, Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation, Eur J Intern Med, 2024;121114-120","journal-title":"Eur J Intern Med"},{"issue":"5","key":"ref13","doi-asserted-by":"publisher","first-page":"e016437","DOI":"10.1161\/JAHA.120.016437","article-title":"Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study","volume":"10","author":"Hsu JY, Liu PP, Liu AB, Lin SM, Huang HK, Loh CH","year":"2021","unstructured":"13. Hsu JY, Liu PP, Liu AB, Lin SM, Huang HK, Loh CH, Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study, J Am Heart Assoc, 2021;10(5):e016437","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"ref14","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1136\/heartjnl-2021-319672","article-title":"Anticoagulant prescribing for atrial fibrillation and risk of incident dementia","volume":"107","author":"Cadogan SL, Powell E, Wing K, Wong AY, Smeeth L, Warren-Gash C","year":"2021","unstructured":"14. Cadogan SL, Powell E, Wing K, Wong AY, Smeeth L, Warren-Gash C, Anticoagulant prescribing for atrial fibrillation and risk of incident dementia, Heart, 2021;107(23):1898-1904","journal-title":"Heart"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12916-022-02563-2","article-title":"Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial","volume":"20","author":"Caramelli B, Yu PC, Cardozo FAM, Magalh\u00e3es IR, Spera RR, Amado DK","year":"2022","unstructured":"15. Caramelli B, Yu PC, Cardozo FAM, Magalh\u00e3es IR, Spera RR, Amado DK, Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial, BMC Med, 2022;20(1):374","journal-title":"BMC Med"},{"issue":"21","key":"ref16","doi-asserted-by":"publisher","first-page":"e009561","DOI":"10.1161\/JAHA.118.009561","article-title":"Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation","volume":"7","author":"Chen N, Lutsey PL, MacLehose RF, Claxton JS, Norby FL, Chamberlain AM","year":"2018","unstructured":"16. Chen N, Lutsey PL, MacLehose RF, Claxton JS, Norby FL, Chamberlain AM, Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation, J Am Heart Assoc, 2018;7(21):e009561","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"ref17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/joa3.12781","article-title":"Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial)","volume":"38","author":"Bunch TJ, May H, Cutler M, Woller SC, Jacobs V, Stevens SM","year":"2022","unstructured":"17. Bunch TJ, May H, Cutler M, Woller SC, Jacobs V, Stevens SM, Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial), J Arrhythm, 2022;38(6):997-1008","journal-title":"J Arrhythm"},{"issue":"7","key":"ref18","doi-asserted-by":"publisher","first-page":"e023098","DOI":"10.1161\/JAHA.121.023098","article-title":"Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study","volume":"11","author":"Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, Garrahy E","year":"2022","unstructured":"18. Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, Garrahy E, Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study, J Am Heart Assoc, 2022;11(7):e023098","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"e209568","DOI":"10.1212\/WNL.0000000000209568","article-title":"Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation","volume":"103","author":"Thunell J, Wood K, Wharton W, Joyce G, Ferido P, Zissimopoulos J","year":"2024","unstructured":"19. Thunell J, Wood K, Wharton W, Joyce G, Ferido P, Zissimopoulos J, Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation, Neurology, 2024;103(1):e209568","journal-title":"Neurology"},{"issue":"4","key":"ref20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.11909\/j.issn.1671-5411.2018.04.004","article-title":"Clinical characteristics and type of antithrombotic treatment in a Spanish cohort of elderly patients with atrial fibrillation according to dependency, frailty and cognitive impairment","volume":"15","author":"Mostaza JM, Jim\u00e9nez MJR, Laiglesia FJR, Peromingo JAD, Robles MB, Sierra EG","year":"2018","unstructured":"20. Mostaza JM, Jim\u00e9nez MJR, Laiglesia FJR, Peromingo JAD, Robles MB, Sierra EG, Clinical characteristics and type of antithrombotic treatment in a Spanish cohort of elderly patients with atrial fibrillation according to dependency, frailty and cognitive impairment, J Geriatr Cardiol, 2018;15(4):268-274","journal-title":"J Geriatr Cardiol"},{"issue":"32","key":"ref21","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation","volume":"39","author":"Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A","year":"2018","unstructured":"21. Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A, Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation, Eur Heart J, 2018;39(32):2942-2955","journal-title":"Eur Heart J"},{"issue":"11","key":"ref22","doi-asserted-by":"publisher","first-page":"e021759","DOI":"10.1136\/bmjopen-2018-021759","article-title":"; Strawberry study investigators. Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study)","volume":"8","author":"Saji N, Sakurai T, Ito K, Tomimoto H, Kitagawa K, Miwa K","year":"2018","unstructured":"22. Saji N, Sakurai T, Ito K, Tomimoto H, Kitagawa K, Miwa K, ; Strawberry study investigators. Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study), BMJ Open, 2018;8(11):e021759","journal-title":"BMJ Open"},{"issue":"23","key":"ref23","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1136\/heartjnl-2021-319672","article-title":"Anticoagulant prescribing for atrial fibrillation and risk of incident dementia","volume":"107","author":"Cadogan SL, Powell E, Wing K, Wong AY, Smeeth L, Warren-Gash C","year":"2021","unstructured":"23. Cadogan SL, Powell E, Wing K, Wong AY, Smeeth L, Warren-Gash C, Anticoagulant prescribing for atrial fibrillation and risk of incident dementia, Heart, 2021;107(23):1898-1904","journal-title":"Heart"},{"issue":"32","key":"ref24","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1093\/eurheartj\/ehy274","article-title":"Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?","volume":"39","author":"Friedman DJ, Granger CB","year":"2018","unstructured":"24. Friedman DJ, Granger CB, Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?, Eur Heart J, 2018;39(32):2956-2958","journal-title":"Eur Heart J"},{"issue":"5","key":"ref25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacasi.2023.07.012","article-title":"Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis","volume":"3","author":"Fong KY, Chan YH, Wang Y, Yeo C, Rosario BH, Lip GYH","year":"2023","unstructured":"25. Fong KY, Chan YH, Wang Y, Yeo C, Rosario BH, Lip GYH, Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis, JACC Asia, 2023;3(5):776-786","journal-title":"JACC Asia"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11239-023-02843-5","article-title":"Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis","volume":"56","author":"Branco DR, Alves M, Severiano E Sousa C, Costa J, Ferreira JJ, Caldeira D","year":"2023","unstructured":"26. Branco DR, Alves M, Severiano E Sousa C, Costa J, Ferreira JJ, Caldeira D, Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis, J Thromb Thrombolysis, 2023;56(3):474-484","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"afad038","DOI":"10.1093\/ageing\/afad038","article-title":"Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study","volume":"52","author":"Grymonprez M, Petrovic M, De Backer TL, Ikram MA, Steurbaut S, Lahousse L","year":"2023","unstructured":"27. Grymonprez M, Petrovic M, De Backer TL, Ikram MA, Steurbaut S, Lahousse L, Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study, Age Ageing, 2023;52(3):afad038","journal-title":"Age Ageing"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-9-2025\/review-issue-9-2025\/comparative-impact-of-direct-oral-anticoagulants-and-vitamin-k-antagonists-on-cognitive-function-in-atrial-fibrillation-patients-a-systematic-review-and-meta-analysis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:05:35Z","timestamp":1763388335000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-9-2025\/review-issue-9-2025\/comparative-impact-of-direct-oral-anticoagulants-and-vitamin-k-antagonists-on-cognitive-function-in-atrial-fibrillation-patients-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["JMedLife-18-821"],"URL":"https:\/\/doi.org\/10.25122\/jml-2025-0071","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}